These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 12090361)

  • 1. 2001 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus.
    US Public Health Service, Infectious Diseases Society of America, Prevention of Opportunistic Infections Working Group
    Infect Dis Obstet Gynecol; 2002; 10(1):3-64. PubMed ID: 12090361
    [No Abstract]   [Full Text] [Related]  

  • 2. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. U.S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA).
    Infect Dis Obstet Gynecol; 2000; 8(1):5-74. PubMed ID: 10741830
    [No Abstract]   [Full Text] [Related]  

  • 3. Preface to the 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. USPHS/IDSA Prevention of Opportunistic Infections Working Group. US Public Health Service/Infectious Diseases Society of America.
    Clin Infect Dis; 1997 Oct; 25 Suppl 3():S299-312. PubMed ID: 9356831
    [No Abstract]   [Full Text] [Related]  

  • 4. 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. USPHS/IDSA Prevention of Opportunistic Infections Working Group. US Public Health Services/Infectious Diseases Society of America.
    Clin Infect Dis; 1997 Oct; 25 Suppl 3():S313-35. PubMed ID: 9356832
    [No Abstract]   [Full Text] [Related]  

  • 5. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. USPHS/IDSA Prevention of Opportunistic Infections Working Group.
    Clin Infect Dis; 1995 Aug; 21 Suppl 1():S32-43. PubMed ID: 8547510
    [No Abstract]   [Full Text] [Related]  

  • 6. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: introduction. USPHS/IDSA Prevention of Opportunistic Infections Working Group.
    Kaplan JE; Masur H; Holmes KK; McNeil MM; Schonberger LB; Navin TR; Hanson DL; Gross PA; Jaffe HW
    Clin Infect Dis; 1995 Aug; 21 Suppl 1():S1-11. PubMed ID: 8547495
    [No Abstract]   [Full Text] [Related]  

  • 7. [Guidelines for the prevention of opportunistic infections in persons with HIV or AIDS in Latin America and the Caribbean. USPHS/IDSA].
    Bol Oficina Sanit Panam; 1996 Nov; 121(5):377-415. PubMed ID: 9011171
    [No Abstract]   [Full Text] [Related]  

  • 8. Trends in pregnancy rates among women with human immunodeficiency virus.
    Blair JM; Hanson DL; Jones JL; Dworkin MS
    Obstet Gynecol; 2004 Apr; 103(4):663-8. PubMed ID: 15051556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current issues in maternal and perinatal tuberculosis: impact of the HIV-1 epidemic.
    Thillagavathie P
    Semin Neonatol; 2000 Aug; 5(3):189-96. PubMed ID: 10956444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary.
    Ann Intern Med; 1996 Feb; 124(3):349-68. PubMed ID: 8554235
    [No Abstract]   [Full Text] [Related]  

  • 11. The obstetric face and challenge of HIV/AIDS.
    Guidozzi F; Black V
    Clin Obstet Gynecol; 2009 Jun; 52(2):270-84. PubMed ID: 19407534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of highly active antiretroviral treatment (HAART) on risk factors for vertical HIV transmission.
    Garcia-Tejedor A; Maiques V; Perales A; Lopez-Aldeguer J
    Acta Obstet Gynecol Scand; 2009; 88(8):882-7. PubMed ID: 19557554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus.
    Ann Intern Med; 1997 Nov; 127(10):922-46. PubMed ID: 9382373
    [No Abstract]   [Full Text] [Related]  

  • 14. 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with HIV: Part I. Prevention of exposure. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention.
    Am Fam Physician; 1997 Sep; 56(3):823-34. PubMed ID: 9301575
    [No Abstract]   [Full Text] [Related]  

  • 15. Introduction to the 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus.
    Masur H; Holmes KK; Kaplan JE
    Clin Infect Dis; 2000 Apr; 30 Suppl 1():S1-4. PubMed ID: 10770910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2001 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus.
    ; ;
    HIV Clin Trials; 2001; 2(6):493-554. PubMed ID: 11742438
    [No Abstract]   [Full Text] [Related]  

  • 18. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus.
    Clin Infect Dis; 2000 Apr; 30 Suppl 1():S29-65. PubMed ID: 10770913
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of mother-to-child transmission of HIV: treatment options.
    McIntyre J
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):971-80. PubMed ID: 16307509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission of HIV.
    Hawkins D; Blott M; Clayden P; de Ruiter A; Foster G; Gilling-Smith C; Gosrani B; Lyall H; Mercey D; Newell ML; O'Shea S; Smith R; Sunderland J; Wood C; Taylor G;
    HIV Med; 2005 Jul; 6 Suppl 2():107-48. PubMed ID: 16033339
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.